SCOPUS 정보 검색 플랫폼

Cancer Biology and Therapy

Volumn 8, Issue 19, 2009, Pages 1798-1799

shRNA technology: Investigating ras-dependent cancer

(3) Stein, Erica V a Price, Douglas K a Figg, William D a

a NATIONAL CANCER INSTITUTE (United States)

Author keywords

Antisense; Cancer; KRAS; PLK1; Ras dependent cancer; shRNA; STK33; Synthetic lethality

Indexed keywords

K RAS PROTEIN; POLO LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE INHIBITOR; PROTEIN STK33; RAS PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANTISENSE THERAPY; GENE IDENTIFICATION; HUMAN; LETHALITY; MITOSIS INHIBITION; NEOPLASM; NONHUMAN; RNA INTERFERENCE; SHORT SURVEY; SYNTHETIC LETHALITY;

GENES, RAS; HUMANS; NEOPLASMS; RAS PROTEINS; RNA, SMALL INTERFERING;

EID: 73549095963 PISSN: 15384047 EISSN: 15558576 Source Type: Journal
DOI: 10.4161/cbt.8.19.9681 Document Type: Short Survey

Times cited : (3)

References (8)

1
- 0030667434
- Integrating genetic approaches into the discovery of anticancer drugs
- Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH. Integrating genetic approaches into the discovery of anticancer drugs. Science 1997; 278:1064-8.
- (1997) Science , vol.278 , pp. 1064-1068
- Hartwell, L.H.¹ Szankasi, P.² Roberts, C.J.³ Murray, A.W.⁴ Friend, S.H.⁵

2
- 25444497278
- The concept of synthetic lethality in the context of anticancer therapy
- Kaelin WG Jr. The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 2005; 5:689-98.
- (2005) Nat Rev Cancer , vol.5 , pp. 689-698
- Kaelin Jr., W.G.¹

3
- 66149091940
- A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene
- Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009; 137:835-48.
- (2009) Cell , vol.137 , pp. 835-848
- Luo, J.¹ Emanuele, M.J.² Li, D.³ Creighton, C.J.⁴ Schlabach, M.R.⁵ Westbrook, T.F.⁶

4
- 26244432934
- Differential expression pattern of the novel serine/threonine kinase, STK33, in mice and men
- Mujica AO, Brauksiepe B, Saaler-Reinhardt S, Reuss S, Schmidt ER. Differential expression pattern of the novel serine/threonine kinase, STK33, in mice and men. Febs J 2005; 272:4884-98.
- (2005) Febs J , vol.272 , pp. 4884-4898
- Mujica, A.O.¹ Brauksiepe, B.² Saaler-Reinhardt, S.³ Reuss, S.⁴ Schmidt, E.R.⁵

5
- 77956270877
- Interference for Cancer Therapy
- Springer New York
- Qin KCaB. RNA Interference for Cancer Therapy. Pharmaceutical Perspectives of Cancer Therapeutics: Springer New York 2009; 399-440.
- (2009) Pharmaceutical Perspectives of Cancer Therapeutics , pp. 399-440
- Qin, K.R.¹

6
- 65849278908
- and drugging the vulnerabilities of RAS-dependent cancers
- Sawyers CL. Finding and drugging the vulnerabilities of RAS-dependent cancers. Cell 2009; 137:796-8.
- (2009) Cell , vol.137 , pp. 796-798
- Finding, S.C.L.¹

7
- 65849111219
- Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells
- Scholl C, Frohling S, Dunn IF, Schinzel AC, Barbie DA, Kim SY, et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 2009; 137:821-34.
- (2009) Cell , vol.137 , pp. 821-834
- Scholl, C.¹ Frohling, S.² Dunn, I.F.³ Schinzel, A.C.⁴ Barbie, D.A.⁵ Kim, S.Y.⁶

8
- 0035845318
- Antisense therapy in oncology: New hope for an old idea?
- Tamm I, Dorken B, Hartmann G. Antisense therapy in oncology: new hope for an old idea? Lancet 2001; 358:489-97.
- (2001) Lancet , vol.358 , pp. 489-497
- Tamm, I.¹ Dorken, B.² Hartmann, G.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.